Compare Ozempic vs Wegovy vs Mounjaro: The Facts
Understanding Ozempic vs Wegovy vs Mounjaro Licensing Differences
The most crucial distinction when comparing Ozempic vs Wegovy vs Mounjaro lies in their UK licensing. Wegovy contains semaglutide and is specifically licensed by the MHRA for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. Mounjaro (tirzepatide) is also licensed for weight management and works as a dual GIP and GLP-1 receptor agonist. However, Ozempic, despite containing the same semaglutide as Wegovy, is licensed exclusively for type 2 diabetes treatment in the UK.
This licensing difference means prescribing Wegovy for weight management constitutes off-label use, which many healthcare providers avoid due to regulatory considerations. When evaluating Ozempic vs Wegovy vs Mounjaro for weight management, both Wegovy and Mounjaro represent the clinically appropriate, licensed options. NICE recommends Wegovy (TA875) with specialist weight management support, whilst Mounjaro has received similar endorsement for weight management applications.
Ozempic vs Wegovy vs Mounjaro Pricing Analysis
When comparing costs for Ozempic vs Wegovy vs Mounjaro, Wegovy starts at £79.99 for the 0.25mg starter dose with discount code FIRST40 applied at checkout. Our Getting Started bundles provide convenient dose progression: the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is £189.99. The maintenance 2.4mg dose is priced at £209.99, with our Consistency 2.4mg bundle (×2 pens) available for £419.99.
Returning customers benefit from code DOSE25 at checkout, ensuring continued affordability throughout their weight management journey. Our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, offering supply security without frequent reordering. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which option aligns with your clinical needs and budget considerations during the assessment process.
Clinical Evidence for Ozempic vs Wegovy vs Mounjaro Weight Management
The STEP clinical trials provide robust evidence for Wegovy's weight management efficacy when evaluating Ozempic vs Wegovy vs Mounjaro options. In STEP 1, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 5 trial demonstrated sustained clinically studied weight loss at two years, whilst STEP 3 showed clinically studied weight loss when combined with intensive behavioural therapy.
Mounjaro's SURMOUNT trials similarly demonstrate significant weight management benefits, though direct comparison between trial results isn't appropriate due to different study designs and populations. The recent SELECT cardiovascular outcomes trial showed Wegovy reduced major cardiovascular events by 20% in patients with established cardiovascular disease, adding another clinical dimension to the Ozempic vs Wegovy vs Mounjaro evaluation for patients with cardiovascular comorbidities.
How Wegovy Works in Ozempic vs Wegovy vs Mounjaro Comparisons
Understanding mechanism differences is essential when comparing Ozempic vs Wegovy vs Mounjaro for weight management. Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. It reduces appetite by acting on brain appetite centres, promotes feelings of fullness after smaller meals, and may help reduce food cravings throughout the day. The once-weekly injection via FlexTouch pen provides consistent therapeutic levels, supporting sustained appetite control alongside dietary modifications. This mechanism differs from Mounjaro's dual GIP and GLP-1 receptor activation, though both approaches target similar metabolic pathways for weight management support.
Ordering Process for Ozempic vs Wegovy vs Mounjaro Assessment
Starting your Ozempic vs Wegovy vs Mounjaro evaluation begins with EverydayMeds' 3-minute online clinical assessment, designed to capture your weight management history, current medications, and treatment goals. Our qualified prescribers review applications within 3 working days (24-hour express option available), ensuring thorough clinical evaluation before recommending between available licensed options. Once approved, next-day delivery via temperature-controlled cold-chain maintains medication integrity from our GPhC-registered pharmacy (#9012878) to your door. The assessment process includes BMI calculation, comorbidity screening, and previous weight management attempts to inform the most appropriate prescription decision. Your prescriber will explain the chosen treatment's dose escalation schedule, administration technique, and monitoring requirements during the consultation process.
Storage Considerations in Ozempic vs Wegovy vs Mounjaro Selection
Practical storage requirements may influence your Ozempic vs Wegovy vs Mounjaro decision, particularly for frequent travellers or those with limited refrigeration access. Wegovy requires refrigeration at 2-8°C before first use but can remain at room temperature (below 30°C) for up to 6 weeks once removed from the fridge. This 6-week room temperature stability exceeds Mounjaro's 21-day limit, providing greater flexibility for travel or temporary storage situations. The FlexTouch pen system includes dose memory and safety features, whilst the mandatory dose escalation from 0.25mg through to 2.4mg maintenance ensures optimal tolerability. Each pen contains 4 weekly doses, and the injection technique remains consistent throughout treatment, simplifying long-term management for patients choosing between the available prescription-only medicine options.
Specialist Prescriber Guidance for Ozempic vs Wegovy vs Mounjaro Decisions
The complexity of choosing between Ozempic vs Wegovy vs Mounjaro necessitates qualified prescriber input rather than self-selection based on online information alone. EverydayMeds prescribers evaluate your complete medical history, current medications, weight management goals, and lifestyle factors to recommend the most clinically appropriate licensed option. This personalised approach considers contraindications, drug interactions, injection frequency preferences, and cost considerations within your individual circumstances.
Our clinical team's expertise extends beyond simple medication supply to ongoing treatment optimisation, side effect management, and dose adjustment guidance throughout your weight management journey. The prescription-only medicine status of both Wegovy and Mounjaro ensures proper medical supervision, whilst our specialists can explain mechanism differences, expected timelines, and realistic outcome expectations based on clinical trial data and real-world experience.
Making Your Final Ozempic vs Wegovy vs Mounjaro Decision
Your Ozempic vs Wegovy vs Mounjaro comparison concludes with understanding that only Wegovy and Mounjaro represent licensed, clinically appropriate options for weight management in the UK. Both treatments require prescription-only medicine status and specialist assessment through our GPhC-registered pharmacy (#9012878). New customers can begin their assessment today using discount code FIRST40, whilst returning patients benefit from DOSE25 savings at checkout. The 3-minute assessment process initiates your personalised treatment journey, with expert prescriber guidance ensuring optimal medication selection based on your individual clinical profile. Start your medically supervised weight management programme by visiting https://everydaymeds.co.uk/collections/wegovy and taking the first step towards evidence-based, professionally supported weight loss treatment.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
